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in General Practices across the UK

altREU 2021
Daramola Oluwasegun Isaac

Scope of Project
To develop a time series forecast model that demonstrates the effect of the pandemic on
Azithromycin prescription and use in the UK

The forecast model is trained with the antibiotic pre-covid dataset, and the model predicts
what the prescription data would have been without the pandemic influence during the
pandemic months(EXPECTED TREND)

The predicted expected trend is then compared with the ACTUAL TREND of Azithromycin
prescription recorded in the course of the pandemic, to observe the effect of the
pandemic.

Choice of Antibiotic
• Azithromycin is a broad spectrum macrolide used for chronic
inflammatory lung disease due to their immunomodulatory
effects, decreasing production of pro-inflammatory cytokines
and inhibiting neutrophil activation.

• There is no justifiable preclinical or clinical evidence to
suggest that the benefits of azithromycin for COVID-19
outweigh the risks of treatment or has antiviral activity
against betacoronaviruses.

Project Timeline
•

31st December, 2019 – Novel virus identified in Wuhan, China

•

31st January, 2020 – First reported COVID-19 case in the United Kingdom

•

23rd March, 2020 – The United Kingdom went into lockdown

•

March 2020 – Month with highest Azithromycin prescription to General Practice, UK
(77856 Azithromycin items)

•

27th May, 2020 – WHO announced Azithromycin not effective, and should not be
administered for treatment or COVID-19 prophylaxis

•

14th December, 2020 – RECOVERY trial finds no benefit from Azithromycin in patients
hospitalized with COVID-19

Patient Population Linear Regression and correlation

Forecast using Time series decomposition

Peculiarity of the Time series
decomposition:
Uses
I - Trend and
II - Seasonality
of the trained dataset to model a
forecast for the predictive values

Azithromycin Prescription Forecast with prediction intervals

Dark Green band – 80% Prediction Interval
Light Green band – 95% Prediction Interval

Control Antibiotic - Metronidazole
Metronidazole had no significant pandemic
prescription influence
Metronidazole has a downward trend across
the years
It also falls in the initial range of Azithromycin
prescription value

Percentage differences
Azithromycin

Control – Metronidazole

Point Forecast cut across actual trend 3 times, indicative of a
relatively weak Actual vs Expected prediction similarity,
hence high divergence due to the pandemic, with a constant
forecast error factor

Point Forecast cut across actual trend 7 times, indicative of a
relatively strong Actual vs Expected prediction similarity,
hence low divergence due to the pandemic, with a constant
forecast error factor

Conclusion
•

Azithromycin prescription spike in March and April significantly influenced by :
– Unjustified, non-randomized, uncontrolled clinical trials
– Increased remote/telephone consultations
– Misinformation

• Model differences show spike in March and April to be significant: 10.23% to 12.15% increase in
actual than expected
– Initial exposure of general practice patients to high Azithromycin dispensation significant to
cause consequent antimicrobial resistant Helicobacter sp., Staphylococcus aureus, Streptococcus
pneumoniae, Streptococcus pyogenes microbes in the UK.
• However, model also shows that consequent months into the pandemic had lower than expected
prescription values
– Hence, there was also significant decrease in Azithromycin use after obvious bland effect in
treatment and prophylaxis

Further probes
• Look at more control antibiotics to observe average divergence of
forecast modeling from actual values
• Alongside Time series decomposition forecast modeling, use other
advance modeling methods to increase accuracy of forecast.
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